Given the crucial role of PARP1 in DNA damage repair and its significant contribution to cisplatin resistance, we aimed to investigate whether the MRPL21-PARP1 axis regulated the sensitivity of HNSCC cells to cisplatin. This evidence concerns the gene PARP1 and head and neck squamous cell carcinoma.